Wuxi Biologics (Cayman) Inc
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 WuXi Biologics is one of the largest biologics contract development and manufacturing organizations in the world. Incorporated in 2014 following the reorganization of WuXi PharmaTech, WuXi engages in full-lifecycle services beginning from drug discovery, clinical trials, and commercial manufacturing. It focuses on developing refining and manufacturing processes to increase scalability and efficiency for pharmaceutical companies looking to outsource and access specialized knowledge. As of 2024, WuXi derives more than 60% of its revenue from US companies and focuses its operations on high-growth, late-stage, and commercial projects in the biologics sector. WuXi competes with Samsung Biologics, Lonza, and Fujifilm for contracts.
公司地址 No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
電話號碼 +86 51085353482
傳真號碼 --
公司網頁 https://www.wuxibiologics.com
員工數量 13252
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Zhisheng Chen Chief Executive Officer and Director -- 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. William Robert Keller Independent Director 29/04/2025
Mr. Jackson Peter Tai Independent Director 29/04/2025
Mr. Yanling Cao Director 29/04/2025
Mr. Kenneth Walton Hitchner, III Independent Director 29/04/2025
Ms. Jingwen Miao Director 29/04/2025
Dr. Zhisheng Chen Chief Executive Officer and Director 29/04/2025
Dr. Ge Li Chairman of the Board 29/04/2025
Dr. Jue Chen Independent Director 29/04/2025
Dr. Weichang Zhou Director 29/04/2025
 
所屬ETF (更新日期: 02/05/2026 02:27)
代號 名稱 佔比% ▼ 持有日期
VSGXVanguard ESG International Stock ETF0.02%31/03/2026
CXSEWisdomTree China ex-State-Owd Entpr ETF0.02%28/04/2026
NUEMNuveen ESG Emerging Markets Equity ETF0.01%29/04/2026
XSOEWisdomTree EmMkts ex-Stt-Ownd EntrprsETF0.01%28/04/2026
GXCState Street® SPDR® S&P® China ETF0.01%29/04/2026
EEMAiShares MSCI Emerging Markets Asia ETF0.01%29/04/2026
BDVLiShares Disciplined Vol Eq Act ETF0.01%10/04/2026
JHEMJHancock Multifactor Em Mkts ETF0.01%29/04/2026
PXHInvesco RAFI Emerging Markets ETF0.01%29/04/2026
FLCHFranklin FTSE China ETF0.01%29/04/2026
DFSEDimensional Emerging Mrkts Sstby Cr 1ETF0.01%27/04/2026
CWIState Street® SPDR® MSCI ACWI ex-US ETF0.01%29/04/2026
WCMEFirst Trust WCM Devpg Wld Eq ETF0.005%29/04/2026
UEVMVictoryShares Emerging Mkts Val MomtETF0.005%29/04/2026
GEMGoldman Sachs ActiveBeta® EMkts Eq ETF0.004%29/04/2026
ECONColumbia Res Enh Emerging Econ ETF0.004%02/02/2026
GMFState Street® SPDR® S&P® Em AsiaPac ETF0.004%29/04/2026
SFTXHorizon International Managed Risk ETF0.004%29/04/2026
EMXFiShares ESG Advanced MSCI EM ETF0.002%28/04/2026
BMEDiShares Health Innovation Active ETF0.002%28/04/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.